Do patients at risk for B-cell malignancy need antiviral treatment?

April 15, 2009

Some studies have shown that a relationship of hepatitis C (HCV) infection with type II mixed cryoglobulinemia exists. However the precise mechanism remains unclear.

A research article to be published on April 7, 2009 in the addresses this question. The research team led by Professor Fan from the Department of Infectious Disease of the People's Liberation Army 161 Hospital in Wuhan used IgH rearrangement and immunohistochemistry. Various research studies indicated a relationship between the B-cell clonality with non-Hodgkin lymphoma, and this article further investigates the risk for developing malignant lymphoproliferative disease in the HCV-infected patients with B-cell clonality in the liver.

Liver-infiltrating monoclonal B-cells were detected in the liver of 4 (10%) of 40 HCV-positive patients but were present in only 3 (0.37%) of 808 liver specimens with chronic HBV infection. Chi-square tesing showed the monoclonal B-cells infiltrating in the liver were more frequent in the HCV-infected patients (P=0.000).A clonal IgH rearrangement was detected in 5 (71.4%) of 7 liver biopsy specimens with monoclonal B-cells infiltration. In 2 of 5 patients with both a clonal B-cell expansion and monoclonal B-cells infiltration in the liver, a definite B-cell malignancy was finally diagnosed.

Recent reports have highlighted the importance of antiviral treatment in the HCV-infected patient with B-cell clonality in the liver. This is the first study to analyze the association of monoclonal B-cells infiltrating in the liver with the B-cell clonality. Furthermore, our follow up study showed that lymphoma developed more frequently in the patients who had monoclonal B-cells infiltration and B-cell proliferation in the liver. The presence of a B-cell clonality and monoclonal B-cells infiltrating in the liver may be useful for detecting patients at high risk for developing malignant lymphoproliferative disease. The study results suggest a strategy for antiviral treatment in patients at risk for B-cell malignancy.

More information: Fan HB, Zhu YF, Chen AS, Zhou MX, Yan FM, Ma XJ, Zhou H. B-cell clonality in the of virus-infected . World J Gastroenterol 2009; 15(13): 1636-1640, http://www.wjgnet.com/1007-9327/15/1636.asp

Source: World Journal of Gastroenterology (news : web)


Rank not rated yet
Relevant PhysicsForums posts

More news stories

Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you

(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...

Medicine & Health / Psychology & Psychiatry

created 12 minutes ago | popularity not rated yet | comments 0

Research finds injuries to professional athletes from routine play or practice often reported as 'freak accidents' in me

(Medical Xpress) -- A new report from the Johns Hopkins Center for Injury Research and Policy finds injuries to professional athletes from routine play or practice are often characterized as “freak accidents” in ...

Medicine & Health / Health

created 7 minutes ago | popularity not rated yet | comments 0

Researchers find rate of follow-up surgeries after partial mastectomy varies greatly

(Medical Xpress) -- A study conducted at the University of Vermont/Fletcher Allen Health Care and three other sites and published in the February 1 issue of the Journal of the American Medical Association found significant ...

Medicine & Health / Cancer

created 21 minutes ago | popularity not rated yet | comments 0

Cognitive impairment in older adults often unrecognized in the primary care setting

A new study published in the Journal of the American Geriatrics Society reveals that brief cognitive screenings combined with offering further evaluation increased new diagnoses of cognitive impairment in older veterans two to ...

Medicine & Health / Diseases

created 2 hours ago | popularity not rated yet | comments 0

Botox developer rues missing out on billions

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Medicine & Health / Medications

created 3 hours ago | popularity not rated yet | comments 0


New molecule has potential to help treat genetic diseases and HIV

(PhysOrg.com) -- Chemists at The University of Texas at Austin have created a molecule that's so good at tangling itself inside the double helix of a DNA sequence that it can stay there for up to 16 days before ...

Researchers' paper wins Best Paper Award for 2011

A paper written by Dr. Paul Gratz and his graduate student, Reena Panda, from the Department of Electrical and Computer Engineering at Texas A&M University was selected as one of the best papers from IEEE Computer Architecture ...

New European rocket lifts off on maiden flight

A new lightweight rocket, Vega, lifted off from Europe's space base Monday carrying nine satellites on its inaugural flight, mission control said.

Ordered planar polymers created for the first time

(PhysOrg.com) -- Scientists under the direction of ETH Zurich have created a minor sensation in synthetic chemistry. They succeeded for the first time in producing regularly ordered planar polymers that form ...

Microsoft India retail site down after 'cyber attack'

Microsoft India's retail website was down on Monday after reportedly being hacked by a Chinese group calling itself Evil Shadow Team.

Chinese city seizes Apple iPads in name dispute

(AP) -- Authorities have seized Apple iPads from retailers in a city in northern China due to a dispute with a domestic company that says it owns the iPad name, an official said Monday. The Chinese company said it is asking ...